Financials
- Financial year
- 2024
- Total assets
- €179,408
- Loss
- -€188,853
- Solvency
- -354.2%
Total assets▼ 37.6%
Net result
20182024
CDI MEDICAL
ActiveThe file of CDI MEDICAL contains 3 judicial reorganisation notices, as published in the Belgian Official Gazette.
Summary
The computed 12-month bankruptcy probability is at least 25% (high). The 2024 annual accounts show negative equity (-€635,552) and a net result of -€188,853. Equity is shrinking by about 36% per year across the filed financial years. Its solvency ranks better than 5% of 6,486 sector peers (NACE 47, financial year 2024).
Overview
Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741
2 sites
Size
€179,408total assets 2024
- Staff
- 4.3 FTE
- Equity
- -€635,552
- Loss
- -€188,853
Why 1raises riskReorganisation plan being carried out (approved, Gazette 12-06-2026)1 change of registered office in 24 months1 financial year not filed after the legal deadline; latest accounts 141 days late; 3 of the last 3 late3 warning signals in 24 months (reorganisation 3)Show the evidence
Checked score
Score 2024
1
/ 100
Critical
Probability in this band: over 15.0%
Financially better than 7% of its sector peers (NACE 47, micro)
Financial strength · tick = 2023
Weak
Solvency
0=
equity -354.2% of total assets
Liquidity
1=
short-term debt 401.7% · cash 1.1%
Profitability
0=
return on assets -105.3%
Bankruptcy probability, 12 months
≥ 25%
High
0%0.5%1.5%4%10%≥ 25%
About 1 in 2 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 10.6%
12-2024: 10.6%● unchanged vs 11-2024
01-2025: 10.6%● unchanged vs 12-2024
02-2025: 11.0%▲ +0.4 percentage points vs 01-2025
03-2025: 10.6%▼ -0.4 percentage points vs 02-2025
04-2025: 10.6%● unchanged vs 03-2025
05-2025: 10.2%▼ -0.4 percentage points vs 04-2025
06-2025: 9.9%▼ -0.3 percentage points vs 05-2025lowest value
07-2025: 10.1%▲ +0.2 percentage points vs 06-2025
08-2025: 10.9%▲ +0.8 percentage points vs 07-2025
09-2025: 11.0%▲ +0.1 percentage points vs 08-2025
10-2025: 11.7%▲ +0.7 percentage points vs 09-2025
11-2025: 17.9%▲ +6.2 percentage points vs 10-2025
12-2025: 18.9%▲ +1.0 percentage point vs 11-2025
01-2026: 14.5%▼ -4.4 percentage points vs 12-2025
02-2026: 14.5%● unchanged vs 01-2026
06-2026: ≥ 25%highest value
07-2026: ≥ 25%● unchanged vs 06-2026highest value
08-2026: ≥ 25%● unchanged vs 07-2026highest value
09-2026: ≥ 25%● unchanged vs 08-2026highest value
10-2026: ≥ 25%● unchanged vs 09-2026highest value
No credit on open account
Liquidity insufficient (current ratio 0.2, compared with 0.38 in 2023, below 1; short-term debt: 401.7% and cash: 1.1% of total assets), and equity is negative.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 6% on solvency, 4% on liquidity, 6% on profitability and 12% on growth.
The bankruptcy probability was computed on 21-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Seven signals.
raises risk
raises risk · Negative equity
The 2024 annual accounts show negative equity and a net loss.
NBB · annual accounts 2024Equity per financial year
18192021222324
2018 to 2024 · latest year -€635,552
raises risk · Annual accounts not filed
The financial year that closed on 31-12-2025 was due at the National Bank by 31-07-2026. Nothing is on record, 83 days later.
NBB · 8 filingsPosition against the passed deadline
31-12-2025 year end31-07-2026 deadline22-10-2026 today
raises risk · Filed more than 90 days late
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 19-12-2025, 141 days past the deadline. Measured on financial year 2023: of the companies more than 90 days late, 5.61% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers.
NBB · 8 filingsDeviation from the deadline
2025
not filed
2024
141 days late
2023
84 days late
2022
35 days late
2021
4 days late
2020
89 days late
2019
122 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 79 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.
Searched, nothing found (1)
- Plan homologationEnterprise Court of Liège ·…
- Filing of a new plan authorisedEnterprise Court of Liège, Namur…
- OpeningEnterprise Court of Liège ·…
Key points
- Risk: Negative equityfinancial year 2024: debts exceed assets -€635,552 View
- Risk: 6 loss-making years in a rowloss financial year 2024 -€188,853 View
- Caution: Among the weakest 5% on solvencysector median 32.6% · 6,486 companies -354.2% View
- Caution: Accounts not fileddeadline was 31-07-2026 83 days late View
- Caution: Equity fell in 2024from -€446,700 to -€635,552 ▼ 42.3% View
By topic
Board & ownership
- Board
- 1 member
- Burhan OCAKOGLUDirector
Timeline
- Events
- 14
- Since
- 2018
- 19-12-2025Annual accounts filed
- 06-10-2025Registered office
- 23-01-2025Resignation: Cristina ACAINAS DIAZ (director)
Company details
- Sites
- 2
- Legal form
- Private limited company
- Activity
- Retail sale of medical and orthopaedic goods, excluding…NACE 47741
- Founded
- 28-12-2016
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What support did similar companies receive that this one did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.